Alvotech And DKSH Extend Partnership For Six Biosimilars

Aim To Target Emerging Asian Markets

Alvogen sister company Alvotech is continuing to extend its network of commercial partners by expanding its partnership with DKSH, a Swiss market expansion services group, for the commercialization of six biosimilars in Asian markets.

Asia
With DKSH’s expertise in Asia, Alvotech plans to commercialize six more biosimilars • Source: Shutterstock

More from Biosimilars

More from Products